CSF3 and Stroke: Following that pattern, granulocyte-colony stimulating factor administration may have a synergic effect with stem cell therapy in stroke by reducing proinflammatory expression and thereby dampening the post-stroke inflammatory environment that inhibits neuroregeneration [179].